Medical News

RSS

World Bank, partner programs 'not achieving intended outcomes' for TB in Africa, report says

A report, released Wednesday by the group ACTION (Advocacy to Control TB Internationally), finds that the World Bank and its partners' programs to fight tuberculosis in sub-Saharan Africa are "not achieving intended outcomes" and have been mostly ineffective, Agence France-Presse reports.

10 Jun 2010

Drinking coffee may help prevent diabetes, report scientists

Scientists are reporting new evidence that drinking coffee may help prevent diabetes and that caffeine may be the ingredient largely responsible for this effect. Their findings, among the first animal studies to demonstrate this apparent link, appear in ACS' bi-weekly Journal of Agricultural and Food Chemistry.

10 Jun 2010

Bayer receives silver Medical Design Excellence Award for CONTOUR USB blood glucose meter

Bayer's CONTOUR® USB meter, the first blood glucose monitor with unique plug & play diabetes management software, today received a silver Medical Design Excellence Award (MDEA). The MDEA recognizes excellence in medical product design and manufacturing. The independent judges for the prestigious award, sponsored by the specialist journal Medical Device and Diagnostic Industry, acknowledged the great innovative power and particularly user-friendly operation of Bayer's CONTOUR USB meter.

10 Jun 2010

Abnormalities in the process of blood clot formation contribute to pathogenesis of AD: Research

New research suggests that abnormalities in the process of blood clot formation may contribute to the pathogenesis of Alzheimer's disease. The study, published by Cell Press in the June 10 issue of the journal Neuron, advances our understanding of the link between vascular pathology and AD and proposes a new therapeutic strategy aimed at slowing cognitive decline.

10 Jun 2010

FDA approves Roxane Laboratories' Valacyclovir Hydrochloride Tablets ANDA

Roxane Laboratories, Inc. announced today the Abbreviated New Drug Application (ANDA) approval of Valacyclovir Hydrochloride Tablets 500mg and

10 Jun 2010

Combination therapy appears to improve outcome of women with late-stage ovarian cancer

The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.

10 Jun 2010

Positive initial results from Nektar Therapeutics' NKTR-102 Phase 2 study for metastatic breast cancer

Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.

10 Jun 2010

GE Healthcare presents interim phase 2 study results of fluciclatide

GE Healthcare, a unit of the General Electric Company, today presented interim phase 2 study results of fluciclatide, in collaboration with the National Cancer Institute, a federal research agency and part of the National Institutes of Health. Fluciclatide is an integrin-targeted radiopharmaceutical under development for oncology PET imaging.

10 Jun 2010

ADF Solutions awarded key patent for digital forensics

ADF Solutions, Inc., the leading provider of forensic triage tools for computers and peripherals, is pleased to announce that it has been granted a patent by the U.S. Patent and Trademark Office pertaining to methods of searching forensic data. The patent has critical applications for forensic triage, cyber-security, cyber-intelligence, digital forensics, and e-discovery.

10 Jun 2010

Microscopic polymer fibers for rebuilding human tissue, speeding healing process

Queen's University Brian Amsden is hoping that in about 10 years a tendon, spinal cord or heart valve will be able to regenerate itself after an injury or disease. The chemical engineering professor, along with scientists from the University of Western Ontario and University of Toronto, is currently trying to develop microscopic polymer fibers to help rebuild human tissue and speed the healing process.

10 Jun 2010

USAID's policy bureau takes shape

Plans for USAID's new Bureau of Policy Planning and Learning are moving ahead, Foreign Policy's blog, "The Cable" reports.

10 Jun 2010

Bristol-Myers Squibb declares quarterly dividend

The Board of Directors of Bristol-Myers Squibb Company today declared a quarterly dividend of 32 cents ($0.32) per share on the $0.10 par value Common Stock of the corporation. The quarterly dividend will be payable on August 2, 2010 to stockholders of record at the close of business on July 2, 2010.

10 Jun 2010

GE Global Research awarded $4M grant to optimize new nerve labeling agent and imaging system

Researchers from GE Global Research announced today that they have been awarded a four-year, $4 million grant from the National Institutes of Health, to optimize a new nerve labeling agent and imaging system. In the future, this agent could help surgeons see delicate nerve endings that are prone to damage during certain procedures, such as prostate surgery.

10 Jun 2010

SFDA approves China Medical Technologies' SPR-based HPV-DNA chip

China Medical Technologies, Inc., a leading China-based advanced in-vitro diagnostic company, today announced that it has received approval for its SPR-based HPV-DNA chip from the State Food and Drug Administration of China (the "SFDA").

10 Jun 2010

Fero Industries enters into Asset Acquisition Agreement with GVEST

Fero Industries, Inc. is pleased to announce that it has entered into an Asset Acquisition Agreement with GVEST Inc., an Ontario Corporation, for the acquisition of certain intellectual property and other associated rights related to the production, marketing, and distribution of Sucanon, a treatment for Type II diabetes.

10 Jun 2010

Overall death rate for patients developed complications during hospitalization fell by 23%: AHRQ

Fewer hospital patients died from complications in their health care between 2001 and 2006, but Asians/Pacific Islanders and Hispanics were less likely to survive than either whites or blacks, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

10 Jun 2010

Global Fund releases mid-year results for HIV, TB, malaria

The Global Fund to Fight AIDS, Tuberculosis and Malaria announced mid-year results for HIV and TB treatment as well as for insecticide-treated net distribution, Sify News reports.

10 Jun 2010

University of Missouri researchers to investigate cadmium's potential for causing endometrial cancer

McDonald's announced a recall recently of 12 million "Shrek"-themed collectible glasses because traces of the toxic metal cadmium were found in them. Cadmium, a silver-white metal, is found in many substances, including certain foods and batteries, and experts believe that it might be a carcinogen. In a new study, University of Missouri researchers will investigate cadmium's potential for causing endometrial cancer.

10 Jun 2010

Autism is caused in part by CNVs: Study

An international consortium of researchers from more than 70 universities, including the University of Utah, has reported that a study of nearly 2,300 people supports the growing consensus that autism is caused in part by rare genetic changes called copy number variants.

10 Jun 2010

Laser pointers may lead to long term damage to the eyes say doctors

In a new warning eye specialists say that hand held laser pointing devices could lead to serious eye damage if used inappropriately. This warning came from the Royal Liverpool Hospital and Manchester Eye Hospital after a teenager developed eye problems after laser light was shone into his eyes.

9 Jun 2010

Medical News

World Bank, partner programs 'not achieving intended outcomes' for TB in Africa, report says

Drinking coffee may help prevent diabetes, report scientists

Bayer receives silver Medical Design Excellence Award for CONTOUR USB blood glucose meter

Abnormalities in the process of blood clot formation contribute to pathogenesis of AD: Research

FDA approves Roxane Laboratories' Valacyclovir Hydrochloride Tablets ANDA

Combination therapy appears to improve outcome of women with late-stage ovarian cancer

Positive initial results from Nektar Therapeutics' NKTR-102 Phase 2 study for metastatic breast cancer

GE Healthcare presents interim phase 2 study results of fluciclatide

ADF Solutions awarded key patent for digital forensics

Microscopic polymer fibers for rebuilding human tissue, speeding healing process

USAID's policy bureau takes shape

Bristol-Myers Squibb declares quarterly dividend

GE Global Research awarded $4M grant to optimize new nerve labeling agent and imaging system

SFDA approves China Medical Technologies' SPR-based HPV-DNA chip

Fero Industries enters into Asset Acquisition Agreement with GVEST

Overall death rate for patients developed complications during hospitalization fell by 23%: AHRQ

Global Fund releases mid-year results for HIV, TB, malaria

University of Missouri researchers to investigate cadmium's potential for causing endometrial cancer

Autism is caused in part by CNVs: Study

Laser pointers may lead to long term damage to the eyes say doctors

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News